115 filings
Page 4 of 6
CORRESP
qujq29tst5y2e8
22 Nov 21
Correspondence with SEC
12:00am
UPLOAD
8om6mo36vg1n jfu
19 Nov 21
Letter from SEC
12:00am
S-3
x2jd njjtjkm
12 Nov 21
Shelf registration
4:02pm
8-K
jvtfej9mde zia0kgd
12 Nov 21
Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update
7:57am
8-K
byyqr431
17 Sep 21
Departure of Directors or Certain Officers
8:32am
8-K
mxkuv8 klwuicba1gipk
12 Aug 21
Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update
10:41am
8-K
y7pgyw7d mdcpt
19 Jul 21
Departure of Directors or Certain Officers
4:53pm
8-K
t4ii3eft6cy
22 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
s7j 0fe1v
12 May 21
Regulation FD Disclosure
9:01am
8-K
h7gwbju
11 May 21
Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update
8:00am
DEFA14A
lafher
29 Apr 21
Additional proxy soliciting materials
4:09pm
DEF 14A
ykirup5kkpq7ej5smxl2
29 Apr 21
Definitive proxy
4:05pm
8-K
8rfea0 rb4axcxh
17 Mar 21
Regulation FD Disclosure
9:02am
S-8
3j7zxp
16 Mar 21
Registration of securities for employees
4:31pm
10-K
gl1i1n f847c2ens5c
16 Mar 21
Annual report
8:20am
8-K
f32ptan 4p05f
16 Mar 21
Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update
8:10am
8-K
8zu1pqg f0b5i7a
8 Mar 21
Departure of Directors or Certain Officers
4:09pm